PLSE

Pulse Biosciences Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth 0/10
  • Momentum 7/10
Pulse Biosciences sales and earnings growth
PLSE Growth
Low
  • Revenue Y/Y 0.00%
  • EPS Y/Y -17.39%
  • FCF Y/Y -49.27%
Pulse Biosciences gross and profit margin trends
PLSE Profitability
Neutral
  • Gross margin -54.00%
  • EPS margin -20794.60%
  • ROIC -750.30%
Pulse Biosciences net debt vs free cash flow
PLSE Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage NA

Pulse Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗